ResearchApr 14, 2022HLA-A∗03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccinationHGG ADVANCES
NewsApr 7, 2022How population genomics is changing clinical care at health systems - 4 takeawaysBeckers
NewsApr 6, 2022HealthPartners seeks 100,000 volunteers to participate in DNA testing programNBC KARE11
VideosApr 1, 2022White House Summit on Strengthening the Nation’s Early Warning System for Health Threats
Press ReleasesMar 23, 2022Thermo Fisher Scientific, Helix and Rosalind to Support National Program to Accelerate SARS-CoV-2 Variant Identification
Press ReleasesHelix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s TreatmentsMay 28, 2025
Press ReleasesHelix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and DevelopmentMarch 18, 2025
Press ReleasesHelix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care ForwardMarch 13, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
2Published ResearchIndividuals with PMS2 pathogenic variants are at average risk of cancer before age 60March 19, 2025
3Published ResearchScalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptionsMarch 19, 2025
4Published ResearchPopulation genomic screening leads to improved lipid management in patients with familial hypercholesterolemiaMarch 19, 2025
5Published ResearchUnderestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetesNovember 21, 2024
